These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antigenic variation of cytomegalovirus isolates recovered from infected children. Lazzarotto T; Boccuni MC; Dal Monte P; Ripalti A; Landini MP Microbiologica; 1991 Jul; 14(3):241-51. PubMed ID: 1656167 [TBL] [Abstract][Full Text] [Related]
3. The oncogenic potential of human cytomegalovirus. Spector DH; Spector SA Prog Med Virol; 1984; 29():45-89. PubMed ID: 6322235 [No Abstract] [Full Text] [Related]
5. Antigenic analysis of human cytomegalovirus isolates from Japanese women and infants. Tanaka A; Numazaki Y Microbiol Immunol; 1979; 23(9):889-97. PubMed ID: 231731 [TBL] [Abstract][Full Text] [Related]
6. Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera. Waner JL; Weller TH Infect Immun; 1978 Jul; 21(1):151-7. PubMed ID: 213383 [TBL] [Abstract][Full Text] [Related]
7. [Cervical cytomegalovirus infection in 194 pregnant women in Beijing]. Fu JL Zhonghua Yi Xue Za Zhi; 1983 May; 63(5):285-8. PubMed ID: 6311369 [No Abstract] [Full Text] [Related]
8. Studies of human cytomegalovirus strain variations by kinetic neutralization tests. Andersen HK Arch Gesamte Virusforsch; 1972; 38(4):297-305. PubMed ID: 4343371 [No Abstract] [Full Text] [Related]
9. Antigenic polypeptides of 3 reference strains recognized by sera from cytomegalovirus (CMV) infected patients. Lery X; Chardonnet Y; Revillard JP Dev Biol Stand; 1982; 52():359-66. PubMed ID: 6187615 [TBL] [Abstract][Full Text] [Related]
10. Neutralization of different strains of murine cytomegalovirus (MCMV)-effect of in vitro passage. Chong KT; Gould JJ; Mims CA Arch Virol; 1981; 69(2):95-104. PubMed ID: 6171240 [TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of virus-infected cells. Larose Y; Tackaberry ES; Brodeur BR Hum Antibodies Hybridomas; 1991 Apr; 2(2):67-73. PubMed ID: 1714785 [TBL] [Abstract][Full Text] [Related]
12. Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. The TH; Klein G; Langenhuysen MM Clin Exp Immunol; 1974 Jan; 16(1):1-7,9-12. PubMed ID: 4143184 [No Abstract] [Full Text] [Related]
13. Comparison of immunological reactivity to two major antigens of homologous and AD169 human cytomegalovirus strains during primary infection in renal transplant patients. Rossier E; Miller H; Dal Monte P; Boccuni C; Landini MP New Microbiol; 1993 Jan; 16(1):1-9. PubMed ID: 8385731 [TBL] [Abstract][Full Text] [Related]
14. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. Navarro D; Lennette E; Tugizov S; Pereira L J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696 [TBL] [Abstract][Full Text] [Related]
15. Proliferative response against cytomegalovirus and prognosis of renal transplant and IgA nephropathy patients. Sakamaki T; Kashiwabara H; Omori K; Nagata N; Hachisu T; Tateno S; Shishido H; Yokoyama T Transplant Proc; 1987 Feb; 19(1 Pt 3):2135-6. PubMed ID: 2856279 [No Abstract] [Full Text] [Related]
17. Early and late antigens of human cytomegalovirus: electroimmunodiffusion assay of numbers, relationships, and reactivities with donor sera. Sweet GH; Bryant SA; Tegtmeier GE; Beneke JS; Bayer WL J Med Virol; 1985 Feb; 15(2):137-48. PubMed ID: 2983008 [TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display. Beghetto E; Paolis FD; Spadoni A; Del Porto P; Buffolano W; Gargano N J Virol Methods; 2008 Jul; 151(1):7-14. PubMed ID: 18499273 [TBL] [Abstract][Full Text] [Related]
20. The oncogenicity of human cytomegalovirus. Huang ES; Mar EC; Boldogh I; Baskar J Birth Defects Orig Artic Ser; 1984; 20(1):193-211. PubMed ID: 6203570 [No Abstract] [Full Text] [Related] [Next] [New Search]